Redx Pharma Plc (REDX.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 05:28PM BST. Market open.
| Previous close | 11.40 |
| Open | 0.00 |
| Bid | 12.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 966,377 |
| Market cap | 58.348M |
| Beta (5Y monthly) | -0.53 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.10 |
| Earnings date | 07 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 130.00 |
PR NewswireJazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor Program
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Redx Pharma plc (AIM: REDX) today announced that the companies have signed a definitive agreement under which Jazz will acquire Redx's KRAS (Kirsten rat sarcoma virus) inhibitor program. Jazz and Redx will collaborate to advance candidates through IND-enabling studies; Jazz will be responsible for all clinical development, regulatory, manufacturing and commercialization activities.
Simply Wall St.Redx Pharma's (LON:REDX) investors will be pleased with their impressive 272% return over the last five years
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
© 2024 Yahoo. All rights reserved.